Ceftazidime-Avibactam versus Colistin for the Treatment of Infections Due to Carbapenem-Resistant Enterobacterales: A Multicenter Cohort Study-Reference-Cited by-同舟云学术

Ceftazidime-Avibactam versus Colistin for the Treatment of Infections Due to Carbapenem-Resistant Enterobacterales: A Multicenter Cohort Study

Published:2022-01 Issue: Volume:Volume 15 Page:211-221
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Almangour Thamer A,Ghonem Leen,Aljabri Ahmad^ORCID,Alruwaili Alya,Al Musawa Mohammed,Damfu Nader,Almalki Mesfer S,Alattas Majda,Abed Hossam,Naeem Doaa,Almalki Nawaf,Alhifany Abdullah A^ORCID

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Reference36 articles.

1. Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections

2. The Centers for Disease Control and Prevention (CDC). Antibiotic resistance threat in the United States; 2019. Available from: https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf. Accessed June 18, 2021.

3. World Health Organization. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics; 2017. Available from: https://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf. Accessed June 18, 2021.

4. International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)

5. Polymyxins for the treatment of lower respiratory tract infections: lessons learned from the integration of clinical pharmacokinetic studies and clinical outcomes

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ceftazidime-avibactam induced renal disorders: past and present;Frontiers in Pharmacology;2024-01-22

2. Reviewing novel treatment options for carbapenem-resistant Enterobacterales;Expert Review of Anti-infective Therapy;2024-01-05

3. Ceftazidime-avibactam alone or in combination with Aztreonam versus Polymyxins in the management of carbapenem-Resistant Klebsiella pneumoniae nosocomial Infections (CAPRI study): a retrospective cohort study from South India;Infection;2023-09-11

4. Use of Ceftazidime-Avibactam for Suspected or Confirmed Carbapenem-Resistant Organisms in Children: A Retrospective Study;Infection and Drug Resistance;2023-09

5. Ceftazidime/avibactam combined with colistin: a novel attempt to treat carbapenem- resistant gram-negative bacilli infection;2023-08-17